IVF pushes your body through a compressed, hormonally intense process that affects nearly every system you can feel: your ovaries swell to many times their normal size, your weight fluctuates, your mood shifts, and your digestion slows down. Most of these changes are temporary, resolving within a few weeks of completing a cycle. But understanding what happens at each stage helps you recognize what’s normal and what deserves a phone call to your clinic.
How Stimulation Hormones Change Your Body
A natural menstrual cycle typically develops one mature egg. IVF overrides that process with daily hormone injections that keep your follicle-stimulating hormone (FSH) levels elevated well above normal, pushing your ovaries to grow multiple follicles at once. FSH binds to cells surrounding each developing egg, triggering them to multiply and produce estrogen. Because of FSH’s short lifespan in the bloodstream, daily injections are necessary to prevent follicles from stalling out.
This stimulation phase lasts roughly 8 to 14 days and drives your estrogen levels far beyond anything a normal cycle produces. Baseline estrogen typically sits around 0.23 nmol/L. By the end of stimulation, levels average 6.24 nmol/L, a roughly 27-fold increase. That surge is what makes multiple eggs mature simultaneously, but it’s also what causes the side effects you feel throughout your body.
Bloating, Swelling, and Weight Changes
Your ovaries normally measure about 3 centimeters across, roughly the size of a walnut. During stimulation, they can swell to 6 or 7 centimeters or more, each one packed with fluid-filled follicles. That enlargement, combined with free fluid that collects in the pelvis, is why bloating is one of the most common complaints. Your pants may feel tight, your lower abdomen heavy, and sitting in certain positions uncomfortable.
Weight gain during a cycle is real but varies widely. One study found an average increase of about 1.3 pounds, mostly from fluid retention, and called it clinically minor. A study of patients with polycystic ovary syndrome (PCOS) found an average gain closer to 5 pounds. But some women experience much more. One well-documented case showed gains of 13 to 15 pounds during each of three stimulation cycles, likely driven by the massive increases in estrogen and progesterone mimicking pregnancy-level hormones. In most cases, this weight drops off after your next period or in the early weeks of pregnancy, because it’s largely fluid rather than fat.
What Egg Retrieval Feels Like
Egg retrieval is a short procedure done under sedation. A needle passes through the vaginal wall into each ovary to drain the follicles. Afterward, you can expect pelvic heaviness, cramping, and sometimes light spotting that’s less than a typical period. Many women return to work the next day, though some take an extra day to rest.
The more significant restriction comes from your still-enlarged ovaries. Until they return to normal size, which takes until your next period (or 6 to 10 weeks into a pregnancy), you should avoid heavy lifting, running, and vigorous exercise. The concern is ovarian torsion, where a heavy, swollen ovary twists on its blood supply. You’re also advised to skip baths, swimming, and vaginal intercourse for several days to let the puncture sites heal.
Progesterone and the Two-Week Wait
After retrieval, your clinic will start you on progesterone to prepare the uterine lining for an embryo. This hormone brings its own set of physical effects: breast tenderness, more bloating, and nausea. These symptoms overlap almost perfectly with early pregnancy signs, which makes the two-week wait between embryo transfer and pregnancy test particularly frustrating. There’s no reliable way to tell from symptoms alone whether you’re pregnant or just responding to the progesterone.
Progesterone also slows digestion. Many women experience constipation or a general feeling of sluggishness in their gut. Staying hydrated and eating fiber-rich foods helps, but the effect persists as long as supplementation continues, typically through the first 8 to 12 weeks of pregnancy if the cycle succeeds.
Mood Shifts and Sleep Disruption
The emotional toll of IVF is partly psychological, the stress of uncertainty and the financial pressure, but it’s also directly hormonal. Estrogen acts on the serotonin system in the brain, influencing the same pathways targeted by antidepressants. It boosts certain serotonin receptors and suppresses enzymes that break serotonin down. When estrogen levels spike during stimulation and then crash after retrieval, those serotonin pathways fluctuate too. The result can be irritability, anxiety, tearfulness, or a low mood that feels out of proportion to what’s happening around you.
Sleep quality often suffers as well, partly from the hormonal swings and partly from physical discomfort. The bloating, breast tenderness, and pelvic pressure make it hard to find a comfortable position, and anxiety about outcomes can make it hard to quiet your mind at night.
Effects on Your Thyroid
The estrogen surge during stimulation doesn’t just affect your ovaries and mood. It also increases the production of a protein that binds thyroid hormone in your bloodstream, effectively reducing the amount of free thyroid hormone available to your cells. Your pituitary gland compensates by raising TSH levels. For most women, this shift is subtle and temporary. But if you have an underactive thyroid or borderline thyroid function, the added demand can push your levels out of range. This is why many clinics monitor thyroid function during IVF, and why your medication dose may need adjusting during a cycle.
Ovarian Hyperstimulation Syndrome
Ovarian hyperstimulation syndrome (OHSS) is the most significant physical risk of IVF stimulation. In its mild form, it’s extremely common: enlarged ovaries, bloating, and mild discomfort that resolves on its own. Moderate OHSS, which involves more significant fluid accumulation and nausea, occurs in roughly 3 to 7 percent of stimulated cycles. Severe OHSS, where fluid shifts into the abdomen and chest and can affect kidney function and blood clotting, occurs in 0.1 to 2 percent of cycles.
Symptoms to watch for include rapid weight gain (several pounds in a day or two), severe abdominal pain, vomiting, difficulty breathing, or decreased urination. Severe OHSS requires hospitalization. Late-onset OHSS can appear up to three weeks after embryo transfer, so the risk window extends well beyond retrieval day. Women who are younger, have a low body weight, or have PCOS face a higher risk.
Bed Rest After Transfer Is Unnecessary
One of the most persistent beliefs about IVF is that you need to lie flat after an embryo transfer to keep the embryo from “falling out.” This was standard advice in early IVF, with clinics recommending 24 hours of bed rest. The evidence tells a different story. When you’re standing, an anteflexed uterus (the most common position) sits nearly horizontal anyway, so gravity isn’t working against implantation. Multiple studies have found that bed rest after transfer provides no benefit, and accumulated data suggest it may actually be associated with worse outcomes. Maintaining your normal daily activity is the current recommendation.
Long-Term Effects on Cancer Risk
Because IVF drugs temporarily flood your body with reproductive hormones, many women worry about long-term cancer risk, particularly breast and ovarian cancer. The largest meta-analysis on this topic, covering 25 studies and more than 617,000 women, found no significant association between fertility treatments and increased breast cancer risk. A comprehensive Danish study with a median follow-up of over 21 years reached the same conclusion.
Earlier, smaller studies occasionally suggested a link, particularly with progesterone use, but those findings haven’t been reproduced in larger populations. Current evidence indicates that IVF does not meaningfully increase overall breast cancer risk, though individual factors like age, genetics, and total hormone exposure may create variations. The scientific consensus treats IVF as relatively safe from a cancer perspective, while acknowledging that very long-term data is still accumulating.